Stock Market Reviews

IRWD (Ironwood Pharmaceuticals, Inc.) News

Get the latest news, insights, and market updates on IRWD (Ironwood Pharmaceuticals, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• 5 Small Drug Stocks to Buy as the Industry Shows Some Recovery
  Innovation is at its peak in the Zacks Medical-Drugs industry. AKBA, IRWD, PYXS, CRDL and PSTV may prove to be good additions to one's portfolio.
  Oct 14, 2025 - $IRWD
• Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term
  Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
  Oct 14, 2025 - $IRWD
• Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
  The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
  Sep 22, 2025 - $IRWD
• EchoStor Technologies Bolsters C-Suite with Appointment of Cale Anjoorian as Chief Information Officer
  EchoStor Technologies, fresh off its recognition on the 2025 Inc. 5000 List and multiple CRN honors, today announced the appointment of Cale Anjoorian as Chief Information Officer. The strategic hire underscores EchoStor's continued momentum and commitment to assembling best-in-class technology leadership as the company scales its enterprise offerings and expands its market presence.
  Aug 25, 2025 - $IRWD
• Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
  Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
  Aug 21, 2025 - $IRWD
• Ironwood Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
  NasdaqGS:IRWD 1 Year Share Price vs Fair Value Explore Ironwood Pharmaceuticals's Fair Values from the Community and...
  Aug 11, 2025 - $IRWD
• IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
  Ironwood shares jump 9.3% as second-quarter earnings and revenues top estimates. The company maintains its 2025 outlook.
  Aug 8, 2025 - $IRWD
• Ironwood: Q2 Earnings Snapshot
  On a per-share basis, the Boston-based company said it had net income of 14 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
  Aug 7, 2025 - $IRWD
• Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
  Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
  Aug 7, 2025 - $IRWD
• Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
  BOSTON, August 07, 2025--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its second quarter 2025 results and recent business performance.
  Aug 7, 2025 - $IRWD